Hebei Changshan Biochemical Pharmaceutical Co., Ltd. (SHE:300255)

SHE:300255 Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May 7, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Market Capitalization	42,360	57,074	18,372	11,957	5,036	7,472
Market Cap Growth	167.81%	210.66%	53.65%	137.41%	-32.59%	31.26%
Enterprise Value	44,467	59,375	20,352	14,091	6,817	8,617
Last Close Price	46.09	62.10	19.99	13.01	5.47	8.09
PE Ratio	-	-	-	-	287.58	31.99
Forward PE	-	12.44	12.44	12.44	12.44	12.44
PS Ratio	48.55	65.22	17.82	8.48	2.16	2.52
PB Ratio	36.16	48.86	11.96	6.64	1.65	2.43
P/TBV Ratio	47.11	64.09	14.65	8.02	1.80	2.68
P/OCF Ratio	-	1024.98	326.80	354.53	1611.41	2602.11
EV/Sales Ratio	50.96	67.85	19.74	9.99	2.92	2.90
EV/EBITDA Ratio	-	-	-	-	41.33	22.68
EV/EBIT Ratio	-	-	-	-	63.13	26.59
Debt / Equity Ratio	1.99	2.20	1.66	1.32	0.82	0.57
Debt / EBITDA Ratio	-	-	-	-	15.10	4.58
Net Debt / Equity Ratio	1.83	2.09	1.50	1.19	0.55	0.39
Net Debt / EBITDA Ratio	-12.68	-14.44	-21.66	-1.99	10.26	3.15
Net Debt / FCF Ratio	-14.22	-36.01	-12.57	-10.39	-3.95	-3.92
Asset Turnover	0.19	0.20	0.23	0.27	0.42	0.61
Inventory Turnover	0.69	0.65	0.62	0.85	0.56	0.60
Quick Ratio	0.21	0.18	0.25	0.29	0.72	0.52
Current Ratio	0.74	0.69	0.91	1.19	2.18	1.97
Return on Equity (ROE)	-26.97%	-27.18%	-15.83%	-51.43%	0.33%	7.81%
Return on Assets (ROA)	-3.27%	-3.33%	-2.45%	-13.46%	1.20%	4.15%
Return on Invested Capital (ROIC)	-6.79%	-6.34%	-4.60%	-26.38%	1.34%	7.22%
Return on Capital Employed (ROCE)	-11.50%	-12.60%	-7.70%	-42.80%	2.50%	9.40%
Earnings Yield	-0.84%	-0.63%	-1.36%	-10.37%	0.35%	3.13%
FCF Yield	-0.36%	-0.12%	-1.00%	-1.72%	-8.50%	-4.08%
Dividend Yield	-	-	-	-	0.09%	0.32%
Payout Ratio	-	-	-	-	708.02%	26.50%
Buyback Yield / Dilution	0.92%	0.68%	-0.58%	-4.91%	6.27%	0.23%
Total Shareholder Return	0.92%	0.68%	-0.58%	-4.91%	6.37%	0.55%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.